KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Accumulated Depreciation & Amortization (2016 - 2025)

Amgen has reported Accumulated Depreciation & Amortization over the past 17 years, most recently at $5.2 billion for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $5.2 billion for Q4 2025, down 7.6% from a year ago — trailing twelve months through Dec 2025 was $5.2 billion (down 7.6% YoY), and the annual figure for FY2025 was $5.2 billion, down 7.6%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.2 billion at Amgen, down from $5.6 billion in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for AMGN hit a ceiling of $5.6 billion in Q4 2024 and a floor of $3.4 billion in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $4.1 billion (2023), compared with a mean of $4.3 billion.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: soared 37.36% in 2024 and later dropped 7.6% in 2025.
  • Amgen's Accumulated Depreciation & Amortization stood at $3.4 billion in 2021, then rose by 0.56% to $3.4 billion in 2022, then grew by 19.14% to $4.1 billion in 2023, then surged by 37.36% to $5.6 billion in 2024, then dropped by 7.6% to $5.2 billion in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $5.2 billion (Q4 2025), $5.6 billion (Q4 2024), and $4.1 billion (Q4 2023) per Business Quant data.